Q-Line Biotech (NSE:QLINE) ROCE %: 24.18% (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech ROCE %?

Q-Line Biotech NSE:QLINE -5.15% 12 ROCE % is 24.18% as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Q-Line Biotech's annualized ROCE % for the quarter that ended in Mar. 2025 was 24.18%.

Q-Line Biotech  (NSE:QLINE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Q-Line Biotech ROCE % Related Terms

Q-Line Biotech ROCE % Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech ROCE % Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
ROCE %
22.95 21.32 24.18

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
ROCE % 22.95 21.32 24.18
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech ROCE % Calculation

Q-Line Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=574.638/( ( (3392.46 - 1402.775) + (4554.859 - 1791.432) )/ 2 )
=574.638/( (1989.685+2763.427)/ 2 )
=574.638/2376.556
=24.18 %

Q-Line Biotech's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=574.638/( ( (3392.46 - 1402.775) + (4554.859 - 1791.432) )/ 2 )
=574.638/( ( 1989.685 + 2763.427 )/ 2 )
=574.638/2376.556
=24.18 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 24.18% mean?
Q-Line Biotech (NSE:QLINE) has a ROCE % of 24.18% as of Mar. 2025.
Is Q-Line Biotech's ROCE % too high?
Q-Line Biotech's current ROCE % is 24.18%. The Medical Devices & Instruments industry median ROCE % is 2.20. Q-Line Biotech's value of 24.18% is 999.1% above this industry median. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's ROCE % compare to ABT and SYK?
Q-Line Biotech's ROCE % of 24.18% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Q-Line Biotech's value of 24.18% is 999.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Q-Line Biotech's current ROCE % of 24.18% is 999.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-Line Biotech's current ROCE % is 24.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current ROCE % of 24.18%. The current ROCE % is 24.18% and 999.1% above the Medical Devices & Instruments industry median of 2.20. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current ROCE % is 24.18% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price